QPS/THI 2014 Summer Webinar Series - Interpreting the Enzyme Induction EMA and FDA Guidance for Industry - August, 2014

This summer, QPS co-hosted a series of five, well-received webinars with The Hamner Institutes for Health Sciences (THI). One of these sessions is conducted by Edward LeCluyse, PhD, Associate Investigator in the Institute for Chemical Safety Sciences at The Hamner Institutes for Health Sciences, and participating faculty member of the Curriculum in Toxicology at The University of North Carolina at Chapel Hill (UNC-CH). Dr. LeCluyse’s talk centers on his interpretation of the Enzyme Induction EMA (European Medicines Agency) and FDA (US Food and Drug Administration) Guidance for Industry, given the basic research aspects of what we currently know about the underlying molecular events.

As a special service to our clients, the complete webinar series has been recorded so that anyone who was unable to attend can still view and listen at his or her convenience.

20 years in pharma R&D navigation